12 June 2026
Latham & Watkins Advises Hercules Capital in an Up to US$300 Million Growth Financing for Leading Biotech Beren Therapeutics
Advising firms
Deal team
7 lawyers named in this releaseThe named deal team is part of full access
Full access opens the named team, the stated value and what it measures, the client and the counterparties, each with the sentence it was taken from.
Stated terms
The stated value, client and counterparties is part of full access
Full access opens the figure exactly as the release prints it, what that figure measures, the client and the counterparties, each with the sentence it came from.